ABSCI CORPORATION - COMMON STOCK

Absci to Participate in the Piper Sandler 35th Annual Healthcare Conference

15 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results

14 Nov 2023 15:05:00 By Nasdaq GlobeNewswire

Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases

14 Nov 2023 01:05:00 By Nasdaq GlobeNewswire

Absci to Participate in Upcoming Investor Conferences

26 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan Cohen

21 Sep 2023 07:00:00 By Nasdaq GlobeNewswire

Absci to Host R&D Day on October 4, 2023

06 Sep 2023 07:00:00 By Nasdaq GlobeNewswire

Absci to Participate in Upcoming Investor Conferences

28 Aug 2023 15:05:00 By Nasdaq GlobeNewswire

Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results

14 Aug 2023 07:02:00 By Nasdaq GlobeNewswire

Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business Officer

14 Aug 2023 07:00:00 By Nasdaq GlobeNewswire

Absci and Caltech Join Forces, Bolstered by Major Grant, to Accelerate Affordable HIV Therapeutic Vaccine Development

10 Aug 2023 07:00:00 By Nasdaq GlobeNewswire

Absci to Participate in the UBS MedTech, Tools and Genomics Summit 2023

01 Aug 2023 07:00:01 By Nasdaq GlobeNewswire

Absci to Participate in the Canaccord Genuity 43rd Annual Growth Conference

26 Jul 2023 07:00:00 By Nasdaq GlobeNewswire

Absci to Participate in the Morgan Stanley 2nd Annual Biotechnology AI Summit

15 Jun 2023 07:00:00 By Nasdaq GlobeNewswire

Absci Evolves its Board of Directors with HealthTech Luminary Frans van Houten, Former CEO of Philips

06 Jun 2023 07:00:02 By Nasdaq GlobeNewswire

Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results

15 May 2023 15:05:00 By Nasdaq GlobeNewswire

University of Oxford’s Kennedy Institute of Rheumatology Partners with Absci to Accelerate AI-Driven Immunotherapies

11 May 2023 07:00:01 By Nasdaq GlobeNewswire

Absci to Participate in the 22nd Annual Needham Virtual Healthcare Conference

06 Apr 2023 07:00:00 By Nasdaq GlobeNewswire

Absci Partners with Bioinformatics Company M2GEN to Accelerate Drug Creation for Oncology

04 Apr 2023 07:00:00 By Nasdaq GlobeNewswire

Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results

30 Mar 2023 15:05:00 By Nasdaq GlobeNewswire

Absci to Participate in the B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation

23 Mar 2023 07:00:00 By Nasdaq GlobeNewswire